SARCOIDOSIS
Clinical trials for SARCOIDOSIS explained in plain language.
Never miss a new study
Get alerted when new SARCOIDOSIS trials appear
Sign up with your email to follow new studies for SARCOIDOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Sarcoidosis drug study halted after just 3 patients
Disease control TerminatedThis study looked at whether the drug maraviroc could reduce inflammation in the lungs of people with sarcoidosis. Three participants took the drug for 6 weeks and had lung fluid tests before and after. The study was stopped early, so results are limited.
Matched conditions: SARCOIDOSIS
Phase: NA • Sponsor: Kevin F. Gibson • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
Sarcoidosis study halted after only 2 patients enrolled
Knowledge-focused TerminatedThis study aimed to see if Acthar gel could improve symptoms and lung function in people with sarcoidosis, a disease that causes inflammation in the lungs. Researchers measured a blood marker called CXCL9 to track the drug's effect. Only 2 people took part before the study was st…
Matched conditions: SARCOIDOSIS
Phase: PHASE4 • Sponsor: University of California, San Francisco • Aim: Knowledge-focused
Last updated May 17, 2026 08:00 UTC